Corrigendum to “Discovery of indazole inhibitors for heat shock protein 90 as anti-cancer agents” [Eur. J. Med. Chem. (2024) 116620]
IF 6
2区 医学
Q1 CHEMISTRY, MEDICINAL
引用次数: 0
Abstract
The authors regret the omission of funding information for grant number 2023R1A2C3004010 in the Acknowledgments section of the original publication. The authors would like to amend the Acknowledgments as follows:求助全文
约1分钟内获得全文
求助全文
来源期刊
CiteScore
11.70
自引率
9.00%
发文量
863
审稿时长
29 days
期刊介绍：
The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers.
A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
